OpenAlex
PricingAboutJobs
Log inGet started
Work

Inclisiran: A Novel Agent for Lowering Apolipoprotein B–containing Lipoproteins

HTML

Year: 2021
Type: review
Source: Journal of Cardiovascular Pharmacology
DOI: 10.1097/fjc.0000000000001053
Authors: Bruce A. Warden, Paul Barton Duell
Institution: Oregon Health & Science University
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: inclisiran, PCSK9, siRNA, apolipoprotein B-containing lipoproteins, LDL cholesterol lowering, hypercholesterolemia, PCSK9 inhibitors, LDL receptor, atherosclerotic cardiovascular disease, lipid-lowering therapy, drug safety and tolerability
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3160485478
FWCI: 2.383
Cites: 99
Cited by: 65
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security